Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000243267 | SCV000313325 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ce |
RCV000585077 | SCV000693204 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | TNXB: BP4, BP7, BS2 |
Gene |
RCV000585077 | SCV001801007 | likely benign | not provided | 2021-01-30 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278179 | SCV002566172 | likely benign | Ehlers-Danlos syndrome | 2020-09-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002392770 | SCV002702825 | likely benign | Cardiovascular phenotype | 2020-01-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |